Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer

International Journal of Cancer

Volumn 92, Issue 3, 2001, Pages 434-440

  Matsushita, A ^a   Onda, M ^a   Uchida, E ^b   Maekawa, R ^b   Yoshioka, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Antitumor effect; Pancreatic cancer; Selective MMP inhibitor

Indexed keywords

MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; MITOMYCIN C; MMI 166; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME NOR; CYTOTOXICITY; DOSE RESPONSE; DRUG INDUCED DISEASE; HAMSTER; IMMUNOHISTOCHEMISTRY; IMPLANTATION; LIVER METASTASIS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SILVER STAINING; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CRICETINAE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; SILVER STAINING; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0035342596     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1199     Document Type: Article

References (31)

1. The spread and prognosis of carcinoma in the region of the pancreatic head
2. Patterns of failure after curative resection of pancreatic carcinoma
3. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
4. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
5. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastasis
6. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinomas
7. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease
8. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma
9. Fighting cancer by attacking its blood supply
10. Angiostatin induces and sustains dormancy of human primary tumors in mice
11. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
12. The relationship between the expression of group-related antigens and cell proliferation of pancreatic carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters
13. Rapid formation of pancreatic tumors by intrapancreatic transplantation of a newly established hamster carcinoma cell line (PGHAM-1) and its sequential analysis
14. Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters
15. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by matrix metalloproteinase inhibitor batimastat (BB-94)
16. Inhibition of organ invasion by matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models
17. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor
18. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
19. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
20. A rapid in vitro assay for quantitating the invasive potential of tumor cells
21. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
22. Nuclear organizer regions in spitz nevi and malignant melanomas
23. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
24. The matrix metalloproteinases and their inhibitors in pancreatic cancer
25. What is the evidence that tumors are angiogenesis dependent?
26. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
27. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
28. Interstitial collagenase is required for angiogenesis in vitro
29. Marimastat (BB2516): Current status of development
30. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
31. Marimastat in patient with advanced pancreatic cancer